Generali Investments Management Co LLC Has $387,000 Holdings in CME Group Inc. $CME

Generali Investments Management Co LLC lessened its position in shares of CME Group Inc. (NASDAQ:CME) by 55.1% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,752 shares of the financial services provider’s stock after selling 2,148 shares during the period. Generali Investments Management Co LLC’s holdings in CME Group were worth $387,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of CME. Empowered Funds LLC lifted its stake in shares of CME Group by 11.5% in the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after purchasing an additional 1,037 shares during the period. Marshall Wace LLP grew its stake in CME Group by 103.1% during the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after purchasing an additional 121,707 shares during the period. Federated Hermes Inc. grew its stake in CME Group by 1,325.2% during the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock worth $6,497,000 after purchasing an additional 21,918 shares during the period. Nebula Research & Development LLC acquired a new stake in CME Group during the second quarter worth approximately $992,000. Finally, The Manufacturers Life Insurance Company increased its holdings in CME Group by 2.6% in the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after purchasing an additional 7,397 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Price Performance

Shares of CME opened at $263.65 on Tuesday. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The business’s fifty day moving average is $249.36 and its 200 day moving average is $280.67. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market cap of $94.80 billion, a P/E ratio of 22.36, a P/E/G ratio of 3.07 and a beta of 0.23.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the business posted $2.96 EPS. CME Group’s quarterly revenue was up .8% on a year-over-year basis. Sell-side analysts anticipate that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 annualized dividend and a dividend yield of 2.0%. CME Group’s payout ratio is presently 44.11%.

Insider Buying and Selling

In related news, insider Hilda Harris Piell sold 5,753 shares of the company’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the sale, the insider owned 27,702 shares in the company, valued at $8,438,860.26. This represents a 17.20% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director William R. Shepard purchased 325 shares of the business’s stock in a transaction on Thursday, June 25th. The shares were bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.30% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. TD Cowen dropped their price target on CME Group from $323.00 to $273.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. JPMorgan Chase & Co. raised their price objective on shares of CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a research report on Thursday, July 23rd. Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective for the company in a research note on Thursday, June 18th. Barclays dropped their target price on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 9th. Finally, Bank of America increased their target price on shares of CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research note on Thursday, July 23rd. Eleven analysts have rated the stock with a Buy rating, four have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $291.81.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.